Polypill Approved for Hypertension, Including as Initial Therapy
The pill comes in three doses and contains telmisartan, amlodipine, and indapamide
Related Articles
Anti-Vaxxers on CDC Panel: A Broken Promise From RFK Jr.?
Being called an anti-vaxxer is a compliment, one new ACIP member says
Polypill Approved for Hypertension, Including as Initial Therapy
The pill comes in three doses and contains telmisartan, amlodipine, and indapamide
Surgical Blood Conservation Technique Falls Short in Trial
Red cell transfusion rates, patient outcomes unchanged with acute normovolemic hemodilution
Zap the Skull to Treat Rheumatoid Arthritis Pain?
Electrical stimulation found effective in small randomized trial
Managing IBD Patients Who Don’t Respond, or Can’t Tolerate, Upadacitinib
Upadacitinib (Rinvoq), a selective Janus kinase 1 (JAK1) inhibitor, is an emerging treatment for inflammatory bowel disease (IBD) and is increasingly used in clinical practice.…
Good News, Mostly, on Preventing Rheumatoid Arthritis
Long-term results could affect practice for at least some patients
Colloid Fluids Square Off Against Normal Saline With Just a Hint of Difference
Large trial neutral overall across hospital settings
People Are Swearing Off Cold Drinks to Prevent Afib
Researchers urge greater attention to ‘cold drink heart’
Investigational Long-Acting Drug Safe in Phenotypic MASH
89% of patients receiving efimosfermin also had at least a 30% reduction in hepatic fat fraction
Upadacitinib in Atopic Dermatitis: Long-Term Effectiveness, Safety in Adolescents
Upadacitinib was found to be effective over the long-term in adolescents with moderate-to-severe atopic dermatitis (AD). Investigators analyzed data from three phase 3 randomized clinical…